"The main patent applications covering sofosbuvir are still pending before the Indian Patent Office," Alton said.

Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell generic Valsartan tablets.

Drug maker Ranbaxy Laboratories today announced receipt of approval from Health Canada to sell generic version of Pfizer's Aricept.

Ranbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...

UCB alongwith others has filed separate cases against as many as 15 drug makers for allegedly infringing its patented drug Vimpat.

Prodded by the Reserve Bank of India, the Tayals, who control Bank of Rajasthan, have begun talks with large private sector banks for a pos...

Ranbaxy Laboratories has received the final approval from the US Food and Drug Administration’s to sell Ramipril capsules (in 5mg & 10mg), ...

India Inc claims that by investing in different sectors in US, the industry is creating work opportunities. Full transcripts: Brainstorming...

Country's biggest pharmaceutical firm Ranbaxy Laboratories on Wednesday said it has received tentative US Food and Drug Administration (USF...

Ranbaxy Labs on Monday announced the launch of two Novel Drug Delivery System (NDDS) products in the Urology Segment. Niftran 100mg Capsule...